title: Autologous cell therapy: will it replace dermal fillers?
abstract: This article discusses autologous cell therapy for wrinkles in the face. Autologous fibroblast therapy is compared with dermal fillers. Study outcomes of LaViv are detailed, including a summary of adverse events. The technique for injection of autologous cells is described in addition to the duration of effect of treatment.
authors.affiliation: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. rweiss@smoothskin.net
authors.forename: Robert A
authors.initials: RA
authors.lastname: Weiss
mesh_terms: D001672:Biocompatible Materials / Q000008:administration & dosage; D002478:Cells, Cultured; D003357:Cosmetic Techniques; D005145:Face; D005347:Fibroblasts / Q000637:transplantation*; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D011300:Preoperative Care; D012060:Rejuvenation; D015595:Skin Aging; D014182:Transplantation, Autologous / Q000009:adverse effects / Q000379:methods
chemical_list: D001672:Biocompatible Materials; D006820:Hyaluronic Acid